When was Truvic founded?

Truvic was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is Truvic located?

Truvic is headquartered in Campbell, United States.

How many employees does Truvic have?

As of Jul 01, 2024, the latest employee count at Truvic is 23.

Is Truvic a funded company?

Truvic is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jul 09, 2020.

When was the latest funding round of Truvic?

Truvic's latest funding was a $***** Series A round on Jul 09, 2020, with participation from 0 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.33B in funding in 2026 to date.

Where does Truvic rank among its competitors?

Truvic ranks 8th amongst 40 active competitors, of which 14 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Cagent Vascular, which secured $41M in May, 2026.

Who are the top competitors of Truvic?

Truvic's top competitors include Okami Medical, LeMaitre Vascular and Cagent Vascular. Among them, Cagent Vascular secured the most recent funding round in May, 2026.

Truvic - 2026 Company Profile, Team, Funding & Competitors

Truvic is an acquired company based in Campbell (United States), founded in 2014. It operates as a Developer of smart devices for peripheral vascular disease management. Truvic has raised $5.89M in funding. The company has 40 active competitors, including 14 funded and 11 that have exited. Its top competitors include companies like Okami Medical, LeMaitre Vascular and Cagent Vascular.

Company Details

TRUVIC is a developer of smart devices for peripheral vascular disease management. It has developed smart devices for peripheral vascular thrombus management by enabling single-session thrombus removal without the use of thrombolytics.

Key Metrics

Founded Year

2014

Location

Campbell, United States

Stage

Acquired

Total Funding

$5.89M in 1 round

Latest Funding Round

Series A, Jul 09, 2020, $*****

Investors

Ascension Ventures & 2 more

Ranked

8^th among 40 active competitors

Employee Count

23 as on Jul 01, 2024

Similar Companies

Okami Medical & 48 more

Exit Details

Acquired by Imperative Care (Jul 15, 2021)

View Truvic's full profile

Truvic got acquired by Imperative Care on Jul 15, 2021.

Click here to take a look at Truvic's acquisition in detail

Truvic has raised a total funding of $5.89M over 1 round. Truvic has 3 institutional investors.

Here is the list of recent funding rounds of Truvic:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 09, 2020	3502578	Series A	2543814	5741595	7436892	7237103

Access funding benchmarks and valuations. Sign up today!

View details of Truvic's funding rounds and investors

Truvic's employee count trend

Truvic has 23 employees as of Jul 24. Here is Truvic's employee count trend over the years:

Uncover Truvic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Truvic include Okami Medical, LeMaitre Vascular and Cagent Vascular. Here is the list of Top 10 competitors of Truvic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Okami Medical 2011, Aliso Viejo (United States), Series F	Developer of innovative, versatile, and intuitive medical devices for peripheral vessels treatment	$107M	Gilde Healthcare, Vensana Capital & 6 others	62/100
2nd	LeMaitre Vascular 1983, Burlington (United States), Public	Vascular surgery solutions innovator, improving patient lives with thoughtfully designed devices	$5.83M	Royce Investment Partners, Conestoga Capital Advisors ... & 1 others	58/100
3rd	Cagent Vascular 2014, Wayne (United States), Series D	Developer of a device for removal of vascular blockages	$110M	USVP, Sectoral & 9 others	58/100
4th	Venturemed Group 2012, Toledo (United States), Series C	Developer of endovascular devices for the treatment of PAD and stenoses of AV fistulas and grafts	$72.2M	Endeavour Vision, RiverVest Venture Partners ... & 3 others	55/100
5th	Pathway Medical Technologies 1998, Kirkland (United States), Acquired	Provider of smart devices to clear peripheral arterial blockages	$102M	LVP, HLM Venture Partners & 8 others	52/100
6th	Avinger 2007, Redwood City (United States), Public	Provider of image-guided catheter-based products for peripheral artery disease	$171M	CRG, Emergent Medical Partners & 6 others	51/100
7th	AtheroMed 2006, Menlo Park (United States), Acquired	Peripheral atherectomy catheter for peripheral arterial disease	$24.7M	Canaan, Kaiser Permanente Ventures & 2 others	42/100
8th	Truvic 2014, Campbell (United States), Acquired	Developer of smart devices for peripheral vascular disease management	$5.89M	Ascension Ventures, AMED Ventures & 1 others	40/100
9th	Eximo Medical 2012, Rehovot (Israel), Acquired	Hybrid catheters for vascular procedures	$1.6M	Accelmed Ventures, Accelmed & 6 others	40/100
10th	Idev Technologies 2000, Houston (United States), Acquired	Self expanding stent system	$58.9M	Piper Jaffray, RiverVest Venture Partners ... & 3 others	39/100